Benzinga | Jan 20, 2021 04:44AM EST

SVB Leerink Maintains Outperform on Guardant Health, Raises Price Target to $190

SVB Leerink analyst Puneet Souda maintains Guardant Health (NASDAQ:GH) with a Outperform and raises the price target from $150 to $190.